Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations. | Adv Sci (Weinh) | 2025 | 40548648 | PubTator, text mining | PubMed |
| Novel ADAR2 variants in children with seizures, intellectual disability, and motor delay have reduced RNA editing. | RNA | 2025 | 40480833 | PubTator, text mining | PubMed |
| Systematic analysis of A-to-I RNA editing upon release of ADAR from the nucleolus. | RNA Biol | 2025 | 40464638 | PubTator, text mining | PubMed |
| Computer-Aided Discovery of Natural Compounds Targeting the ADAR2 dsRBD2-RNA Interface and Computational Modeling of Full-Length ADAR2 Protein Structure. | Int J Mol Sci | 2025 | 40362314 | PubTator, text mining | PubMed |
| Decoding microRNA arm switching: a key to evolutionary innovation and gene regulation. | Cell Mol Life Sci | 2025 | 40347284 | PubTator, text mining | PubMed |
| Identification of shared pathophysiological molecules of major psychiatric disorders: A comprehensive analysis of serum immune complex antigens before and after electroconvulsive therapy. | J Neuroimmunol | 2025 | 40306147 | PubTator, text mining | PubMed |
| SPRINGing forward: Advancing RNA editing efficiency and precision with engineered ADAR2. | Mol Ther Nucleic Acids | 2025 | 40226329 | PubTator, text mining | PubMed |
| Structural insights into RNA-guided RNA editing by the Cas13b-ADAR2 complex. | Nat Struct Mol Biol | 2025 | 40217120 | PubTator, text mining | PubMed |
| A Multi-Input Neural Network Model for Accurate MicroRNA Target Site Detection. | Noncoding RNA | 2025 | 40126347 | PubTator, text mining | PubMed |
| Roles for Androgen Receptor, ADAR2, and PD-L1 in Primary Urothelial Carcinoma In Situ of the Bladder Treated with Bacillus Calmette-Guérin Therapy. | Lab Invest | 2025 | 40010639 | PubTator, text mining | PubMed |
| Enhancing RNA editing efficiency and specificity with engineered ADAR2 guide RNAs. | Mol Ther Nucleic Acids | 2025 | 39967855 | PubTator, text mining | PubMed |
| Clinico-genetic Analysis of Adenosine Signaling Pathway in Drug-Resistant Epilepsy. | Ann Indian Acad Neurol | 2025 | 39951024 | PubTator, text mining | PubMed |
| Structural analysis of human ADAR2-RNA complexes by X-ray crystallography. | Methods Enzymol | 2025 | 39870445 | PubTator, text mining | PubMed |
| ADAR Therapeutics as a New Tool for Personalized Medicine. | Genes (Basel) | 2025 | 39858624 | PubTator, text mining | PubMed |
| A circularly permuted CasRx platform for efficient, site-specific RNA editing. | Nat Biotechnol | 2025 | 39385008 | PubTator, text mining | PubMed |
| Consistent RNA expression and RNA modification patterns in cardiotoxicity induced by Matrine and Evodiamine. | Front Pharmacol | 2024 | 39850555 | PubTator, text mining | PubMed |
| Development and validation of a 6-gene signature derived from RNA modification-associated genes for the diagnosis of Acute Stanford Type A Aortic Dissection. | J Geriatr Cardiol | 2024 | 39483269 | PubTator, text mining | PubMed |
| Nanocarriers Targeting Circular RNA ADARB1 Boost Radiosensitivity of Nasopharyngeal Carcinoma through Synergically Promoting Ferroptosis. | ACS Nano | 2024 | 39467079 | PubTator, text mining | PubMed |
| The role of dsRNA A-to-I editing catalyzed by ADAR family enzymes in the pathogeneses. | RNA Biol | 2024 | 39449182 | PubTator, text mining | PubMed |
| Post-Transcriptional Modifications to miRNAs Undergo Widespread Alterations, Creating a Unique Lung Adenocarcinoma IsomiRome. | Cancers (Basel) | 2024 | 39409941 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=4